Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)

Introduction: Preclinical studies have demonstrated the possible role of beta-adrenergic receptors in pancreatic ductal adenocarcinoma (PDAC) tumor invasion and migration. The current study aimed to explore the possible association between survival outcomes and beta-blocker (BB) exposure in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Bozec, Antoine, Brugel, Mathias, Djerada, Zoubir, Ayad, Marya, Perrier, Marine, Carlier, Claire, Botsen, Damien, Nazeyrollas, Pierre, Bouché, Olivier, Slimano, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235451/
https://www.ncbi.nlm.nih.gov/pubmed/37274119
http://dx.doi.org/10.3389/fphar.2023.1137791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235451/
https://www.ncbi.nlm.nih.gov/pubmed/37274119
http://dx.doi.org/10.3389/fphar.2023.1137791

Ejemplares similares